Common questions about Flaxendol (FAQ)
Q: Can Flaxendol be taken with common over-the-counter pain relievers?
A: Regulatory guidance advises against combining Flaxendol (Naproxen) with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, due to the potential for increased risks. However, official documents generally state that Flaxendol may be taken with acetaminophen (Paracetamol) for short periods, as these are different classes of medicine.
Q: Can older people typically use Flaxendol?
A: Older adults may use Flaxendol, but official documents indicate they are at a greater risk for serious gastrointestinal and kidney-related adverse events. For this reason, official use guidelines note that this population may require close monitoring and the use of the lowest effective dose.
Q: Is Flaxendol safe to take if I am pregnant or planning to be?
A: Official regulatory documents state that Flaxendol is contraindicated (must not be used) from the 30th week of pregnancy onward due to documented risks to the fetus. Official documentation indicates that use between 20 and 30 weeks requires special medical consideration and should be limited due to the potential for fetal renal dysfunction.
Q: Can Flaxendol be used for long-term conditions?
A: Flaxendol is officially indicated for the management of chronic conditions like Rheumatoid Arthritis. However, official prescribing information emphasizes using the medicine at the lowest effective dose for the shortest duration necessary, as risks may be associated with prolonged use.
Q: Are the side effects of Flaxendol permanent?
A: Official documentation describes serious adverse reactions as potentially life-threatening cardiovascular events or severe gastrointestinal events. Common adverse reactions like dyspepsia or headache are often noted to resolve when the medicine is stopped, but regulatory documents do not provide a blanket statement on the permanence or reversibility of all effects.
Q: Does Flaxendol interact with alcohol?
A: Official information states that concurrent use of Flaxendol with alcohol increases the risk of serious gastrointestinal bleeding. Due to this increased risk, the concomitant use of alcohol is generally discouraged in official warnings.
Q: Are there specific symptoms that mean I should stop taking Flaxendol immediately?
A: Official regulatory warnings instruct patients to seek immediate medical attention if they experience signs of serious bleeding (such as passing bloody or black, tarry stools) or signs of a severe allergic reaction (such as difficulty breathing, swelling, or a severe rash). These are listed as serious symptoms requiring immediate medical attention.
Q: How is the safety of Flaxendol monitored after it is released to the public?
A: Safety is continuously monitored by governmental bodies through a mandatory system of post-marketing surveillance. This official process requires the collection and analysis of reports on adverse events submitted by healthcare professionals and patients to ensure ongoing safety evaluation.
Q: Is Flaxendol generally suitable for children?
A: Flaxendol is approved and has official weight-based dosing guidelines for pediatric patients, typically those over 2 years of age, for specific conditions like Juvenile Idiopathic Arthritis. Official information states that for most uses outside of these specific indications, safety and effectiveness are typically not established in younger pediatric patients.
Q: Does Flaxendol have any specific warnings for individuals with heart conditions?
A: Yes, official warnings include a boxed warning regarding an increased risk of serious cardiovascular thrombotic events, such as heart attack and stroke. Use is contraindicated following Coronary Artery Bypass Graft (CABG) surgery, and official information indicates use may be avoided in patients with severe heart failure.
Q: Is it true that Flaxendol might affect sleep?
A: The official safety profile lists nervous system adverse reactions that can affect a patient's rest. These include 'somnolence' (drowsiness) and, less commonly, reactions such as 'insomnia' or 'nervousness' in some individuals.
Q: How long does it usually take for Flaxendol to start working?
A: The onset of action is dependent on the medicine’s specific formulation. The highly soluble sodium salt is typically noted to begin its effect within 30 minutes to 1 hour, whereas the free-acid formulation is associated with a slightly slower onset.
Q: How long does Flaxendol stay in your system after stopping?
A: According to official pharmacokinetic data, Naproxen has an average plasma elimination half-life ranging from 12 to 17 hours. This half-life defines the time required for the body to eliminate half of the medicine from the bloodstream.
Q: Does Flaxendol have a risk of dependence or addiction?
A: Flaxendol (Naproxen) is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). It is not categorized as a controlled substance, narcotic, or opioid, and official documents do not associate it with a risk of psychological or physical dependence or addiction.
Q: Can Flaxendol cause changes in mood or anxiety levels?
A: The official safety profile occasionally lists central nervous system effects, such as 'mental confusion,' 'depression,' and 'nervousness,' under uncommon or rare adverse reactions. These types of reactions may be perceived as changes in mood or anxiety by some patients.
Q: Is it okay to drive while taking Flaxendol?
A: The official safety profile lists potential side effects such as dizziness, drowsiness (somnolence), or lightheadedness. Because of these potential effects, official guidance states that caution is required, and activities such as driving or operating heavy machinery should be approached carefully until the effects of the medicine are known.
Q: Do you gain weight when taking Flaxendol?
A: The official safety profile lists fluid retention and edema (swelling) as common adverse reactions. These specific effects, which involve the retention of water in the body, may be associated with changes in body weight.
Q: Is Flaxendol a narcotic or opioid?
A: No, Flaxendol (Naproxen) is a Non-Steroidal Anti-Inflammatory Drug (NSAID) and is not classified as a narcotic or opioid controlled substance. It works through a different mechanism than opioid pain relievers.
Q: Can Flaxendol affect my ability to concentrate?
A: The safety profile lists adverse effects such as dizziness and mental confusion under nervous system disorders. These types of reactions may temporarily affect a patient's ability to focus or concentrate.
Q: What makes Flaxendol different from over-the-counter options for the same condition?
A: Flaxendol contains the same active ingredient as over-the-counter Naproxen. The primary difference is regulatory: prescription Flaxendol is available in higher dosage strengths and may be considered for longer periods of use for chronic conditions under medical supervision.
Q: Are there any known interactions between Flaxendol and birth control pills?
A: Official regulatory documents and drug interaction lists for Naproxen do not typically list a major or moderate interaction with common hormonal contraceptives (birth control pills).
Q: What should I know about taking Flaxendol and having surgery?
A: Regulatory warnings state that Flaxendol is officially contraindicated (must not be used) in the perioperative setting of Coronary Artery Bypass Graft (CABG) surgery, which is an official regulatory restriction due to documented risks.
Q: When was Flaxendol first approved for use?
A: The active ingredient in Flaxendol, Naproxen, was initially approved by the U.S. Food and Drug Administration (FDA) in 1976, establishing its long history of regulatory review and use.
